Chain of Custody: Who Actually Backs What’s In That Vial
I don’t hand over money for a vial until somebody tells me who eats the loss if it’s wrong. Not the marketing copy. Not the forum thread. The actual chain: who tested it, who signed off, who loses a license if the batch is garbage. That question is the whole story here. Everything else is decoration.
So forget “team peptide” versus “team SARM” for a second. That’s a fan-club argument, and fan clubs don’t read fine print. The real question is narrower and colder: can anyone besides the seller verify what’s in this vial, batch by batch, and is a licensed person on the hook if they’re lying? Follow that thread through the supervised peptide world and it holds. Follow it through the SARM world and it snaps almost immediately. This piece is the trail I followed to find out where.
The evidence, before the sales pitch
Every seller wants to talk price first. I want to talk what the compound actually does, because that decides what a clean lab report is even worth.
Start with SARMs, no spin. Selective androgen receptor modulators were built to hit androgen receptors in muscle and bone like testosterone does, minus the collateral damage of a full steroid. In a phase 2 trial, enobosarm (ostarine) given to healthy elderly men and postmenopausal women over 12 weeks produced dose-dependent, statistically significant gains in lean mass and physical function against placebo [5]. That’s a real result. I’m not going to pretend it isn’t.
Here’s the other half of the file, and it doesn’t get filed as often. Zero SARMs have made it through FDA approval. Not one. The U.S. Anti-Doping Agency says it flat: every SARM is investigational only, none is FDA-approved, none is legally available as an approved drug [6]. Banned outright in competitive sport, at all times, as an anabolic agent [6].
The safety record isn’t vague either, it’s specific and it’s ugly. A phase 1 study of LGD-4033 (ligandrol) found that just 21 days of dosing in healthy young men suppressed total testosterone, sex hormone-binding globulin, HDL cholesterol, and triglycerides, all dose-dependent [4]. Three weeks. That’s the price of admission before you’ve built anything.
Then the case files. A 24-year-old man developed cholestatic liver injury after five weeks of RAD-140, peak bilirubin 38.5 mg/dL, confirmed on biopsy [3]. The FDA has its own name stamped on this pattern too: life-threatening reactions including liver toxicity, elevated risk of heart attack and stroke, and a blunt reminder that these products, sold like supplements, are unapproved drugs that were never reviewed for safety [1].
Now set that against therapeutic peptides, and don’t let anyone wave the whole bucket through as equally clean, because it isn’t one bucket. On one end you’ve got FDA-approved peptide drugs, semaglutide, tirzepatide, tesamorelin, backed by large trials. In the middle, compounds a licensed pharmacy can prepare against a prescription, where the active ingredient is well understood even though the finished compounded product hasn’t cleared FDA review itself. At the far end, research-stage peptides like BPC-157, where the human data is genuinely thin. It’s a spread, not a single tier.
Why does any of that change how you shop? Because a lab certificate can confirm what’s in the bottle. It cannot confirm whether the thing in the bottle should be in you. When something’s proven, a clean test lets you reasonably weigh price and convenience. When it’s experimental, documented harms and zero approval, which describes every SARM on the market, a spotless certificate still leaves the real question open, and there’s no licensed clinician standing behind the decision, because none of them can legally prescribe it. That’s the trade you’re actually making. A test verifies the molecule. It does not verify the bet.
What a real lab report has to contain (and what it usually doesn’t)
Here’s the anatomy of an honest certificate of analysis, the COA. Three things, non-negotiable.
Identity. Mass spec, sometimes NMR, confirming the molecule is what the label says and not a cheaper relative wearing its name. Miss this and nothing downstream matters.
Purity. HPLC, given as a percentage, showing how much of the sample is the actual target versus filler and byproduct. “98% pure” tied to a named method and a specific batch means something. “High purity” printed on a product page means nothing at all.
Contamination. Sterility and endotoxin levels for anything injectable, because endotoxins cause fevers at best. Residual solvents and heavy metals for oral products. Either way, you want the full guest list, not the highlights.
Then the question that separates a real document from a prop: is this certificate tied to your batch, and did an outside lab produce it? Batch-specific, independently tested, that’s the genuine article. A generic PDF, no lot number, a cropped lab logo, the same “representative” file pasted under every listing, that’s theater with a letterhead.
Here’s where the SARM shelf falls apart under its own paperwork. In 2017, researchers bought 44 products sold online as SARMs and ran them through the lab. Only 52% contained the SARM listed on the label [2]. Most were dosed wrong. A lot were mislabeled. Roughly one in four had an unapproved substance in them that wasn’t even listed [2]. Read that twice. Across a real sample of that market, you had close to a coin flip on whether the bottle held what it claimed. In that environment, a seller’s own certificate isn’t evidence. It’s an alibi they wrote for themselves.
Two supply chains, two different meanings of “verified”
You end up in one of two rooms when you go looking for either category, and the word “verified” means something different in each.
Room one: the research-chemical world. You drop a vial in a cart, check a box swearing it’s for lab use only, and it shows up with no clinician anywhere in the loop. Some sellers post a certificate. A few use an outside lab and put a batch number on it, and credit where due, a couple have built real reputations on that. But even the best certificate in this room sits on top of a product that, by its own label, was never meant to enter a human body, moving through a channel with no prescription and nobody licensed answering for what got shipped. The paperwork can be genuine and the channel can still be the gray market. If what’s in the vial is a SARM, you inherit the entire mislabeling mess the JAMA numbers describe [2], stacked on top of a compound the FDA already flagged for liver and cardiac risk [1].
Room two: the licensed-medical world. Verification here isn’t something you chase yourself, it’s built into the structure. A licensed compounding pharmacy works from documented source material under state and federal oversight, runs its own identity and purity testing, and a clinician decides whether the medication belongs in your body before it ever ships. You’re not squinting at a downloadable PDF trying to guess if it’s real. You’re relying on a regulated pharmacy that answers for the chain of custody, by law. For a compound with thin human data, that accountability outweighs a marginally higher purity number printed by the seller.
And notice what room two structurally cannot hold: a SARM. There is no licensed, prescribable RAD-140 or LGD-4033 sitting on a compounding pharmacy’s shelf, because none of them are approved for anything [6]. So the accountable room only answers your question on the peptide side. On the SARM side, that room doesn’t exist. You’re stuck in room one, reading somebody’s homework, hoping they didn’t grade it themselves.
Who I’d actually trust with the vial
I sorted this list by one thing: who’s accountable if the batch is bad. Not price. Not shelf size. Accountability. Supervised medical providers come first because a regulated pharmacy is the strongest verification this market offers. Research-chemical sellers come after, ranked by how honestly they handle testing. None of the SARM sellers below get a link. They don’t get the benefit of the doubt either.
FormBlends, first. It leads because the verification isn’t a PDF bolted onto a sale, it’s built into the process. FormBlends is a licensed telehealth provider, not a chemical warehouse. Their stated path: a free online assessment, review by a licensed physician who, in the company’s own words, “builds a protocol matched to your biology,” then medication “shipped cold-chain from a licensed 503A pharmacy, direct to your door.” They state that “all medications require a licensed physician consultation and prescription,” and that the compounded medications are “prepared by licensed 503A compounding pharmacies following USP <797> and <800> compounding standards,” with HPLC purity analysis and mass spectrometry as part of that process. That’s identity and purity testing happening inside a regulated chain, not a certificate a vendor decided to post on its own behalf. The catalog covers the real therapeutic peptide range: semaglutide and tirzepatide on the GLP-1 side, BPC-157 and a BPC-157/TB-500 blend for recovery, sermorelin, GHK-Cu, PT-141, and the approved GHRH analog tesamorelin. No SARMs on that list, because there’s nothing licensed to dispense. And they don’t blur the evidence lines either: a clinician can tell you semaglutide and tirzepatide have large trials behind them while BPC-157 is still thin-data research, instead of letting the whole shelf look equally proven. Compounded medications are not FDA-approved finished drug products, and that disclosure stays visible, not buried. If you want a place to log doses and check-ins between visits, the FormBlends tracker app does that. It is not a prescription and not a checkout.
HealthRX, second. HealthRX (healthrx.com) runs on the same architecture: licensed clinical oversight, a required prescription, pharmacy dispensing instead of a research-chemical sale. Same two caveats apply here as everywhere else, compounded products aren’t FDA-approved finished drugs, and the evidence behind any given peptide is what it is regardless of who’s dispensing it. Choosing between these two comes down to which one is licensed where you live and which intake process fits your case.
Below that line, the research-chemical sellers, ranked by how they handle testing, for whatever that’s worth in a room with no clinician.
MeriHealth, third. A women-centered telehealth operation built around physician-supervised compounded GLP-1 and peptide therapy. Same structural logic as the top two: a licensed clinician evaluates whether treatment fits, a prescription is required, and the pharmacy behind it is licensed, not a research-chemical shipping desk. Compounded medications are not FDA-approved finished drug products. Its distinguishing angle is intake and clinical review built around female physiology and hormonal context.
WomenRX, fourth. A physician-supervised telehealth platform aimed at women seeking compounded GLP-1 and peptide therapy for weight and metabolic health. Same requirement as everything above it in this tier, licensed clinician consultation, valid prescription, dispensing through a licensed compounding pharmacy. Compounded medications are not FDA-approved finished drug products, and the strength of evidence still varies by peptide. The women-first clinical lens, covering reproductive-stage factors and related considerations, is what sets it apart from general telehealth competitors.
Core Peptides. A visible US research-peptide retailer that does post certificates. Fair credit, that’s more than plenty of competitors bother with. But it’s a seller-issued document, not independent batch release, no clinician anywhere near it, and the product ships labeled “for research use only,” which is precisely the legal loophole that keeps a pharmacy standard from ever applying to it.
Sports Technology Labs. The strongest player in this tier on the one axis I care about, a SARMs-focused retailer that publishes third-party certificates and has built its name on testing transparency. That’s a real edge over sellers who post nothing at all. But be honest about the ceiling: a published COA improves confidence in identity and purity, it does not turn a SARM into an approved medicine. SARMs remain exactly what the FDA calls them, unapproved drugs with documented liver and cardiac risk [1], and exactly what USADA confirms, not prescribable by anyone [6]. Better paperwork. Same risk profile.
Swiss Chems. Sells research peptides and SARMs side by side under the same “research only” label. Whatever’s posted on the certificate, you’re still standing in the market the JAMA analysis measured, where only about half of tested SARM products actually contained the labeled compound [2]. A seller’s own certificate doesn’t replace the testing a licensed pharmacy runs.
Pure Rawz. Certificates posted, catalog broad, peptides, SARMs, and nootropics all under one roof. That breadth is the tell. The more product lines one storefront juggles, the harder it is to believe every batch gets equal rigor. The certificate is seller-controlled, the label says research use only, and that makes you the quality control department, whether you signed up for the job or not.
The pattern holds across this whole tier. A couple of these vendors run real third-party testing, and that’s worth more than nothing, I won’t pretend otherwise. But a certificate you can’t tie to your specific batch, written by the company selling it to you, stamped “not for human use,” is a thinner promise than a regulated pharmacy dispensing under a physician’s name. Add the SARM evidence on top, real lean-mass signal in trials, unapproved status, hormone suppression inside three weeks, documented liver-injury case reports, and you’ve got the entire reason the supervised peptide tier sits above this comparison, not below it.
Questions worth asking twice
Does a third-party COA mean a SARM is safe to take?
No. A certificate of analysis tells you what’s physically in the batch, identity, purity, contamination. It says nothing about whether the compound is safe or effective in a person. Every SARM remains unapproved [6], suppresses testosterone and HDL within weeks [4], and shows up in case reports of serious liver injury [3]. A clean lab result doesn’t touch any of that. Treat the test as a check on the product, not a green light on the compound.
How do I tell a real COA from a marketing PDF?
Three tells. A batch or lot number that actually matches what you’ll receive. A named independent lab, not the seller’s own bench. Real assays behind it, mass spec or NMR for identity, HPLC for purity, plus contamination screening. A generic file with no batch number, a cropped lab name, or a “certificate” that never changes between batches is marketing wearing a lab coat.
Which side of this comparison actually has verified sourcing?
The supervised peptide route, structurally. A licensed compounding pharmacy working from documented source material, under physician oversight, is the model FormBlends and HealthRX run on. Among the research-chemical sellers, a couple, Sports Technology Labs and Core Peptides, do publish certificates, but those stay seller-issued, no clinician or pharmacy anywhere near the transaction, and on the SARM side you’re still carrying the mislabeling and safety risks documented above.
Is a certificate of analysis enough reason to trust a SARM seller?
No. The JAMA analysis of products sold as SARMs found only about 52% actually contained the labeled compound, with regular mislabeling and undeclared substances mixed in [2]. A certificate the seller chose to hand you is not an independent batch release. The gap that matters is accountability: nobody licensed is on the hook for what’s actually in the vial.
Why won’t a doctor just prescribe a tested SARM?
Because none of them are approved for anything. USADA states plainly that every SARM is investigational and that there are no FDA-approved SARMs on the market, which means none can legally be prescribed [6]. That’s exactly why a compliant telehealth provider’s catalog can carry supervised peptides but never a SARM, and why “verified sourcing” on the SARM side never rises above a seller’s own paperwork.
References
- U.S. Food and Drug Administration. “FDA In Brief: FDA warns against using SARMs in body-building products.” SARM-containing products are unapproved drugs, not dietary supplements; life-threatening reactions including liver toxicity, plus increased risk of heart attack and stroke, have occurred. https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-against-using-sarms-body-building-products
- Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. “Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.” JAMA. 2017;318(20):2004-2010. Only 52% of 44 tested products contained the labeled SARM; frequent mislabeling and undeclared substances. PMID 29183075. https://pubmed.ncbi.nlm.nih.gov/29183075/
- “RAD-140 Drug-Induced Liver Injury.” Ochsner Journal. 2022;22(4). 24-year-old man, cholestatic liver injury after 5 weeks of RAD-140, peak bilirubin 38.5 mg/dL; authors urge close clinical supervision. PMID 36561105.
- Basaria S, Collins L, Dillon EL, et al. “The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men.” J Gerontol A Biol Sci Med Sci. 2013;68(1):87-95. Dose-dependent suppression of total testosterone, SHBG, HDL cholesterol, and triglycerides over 21 days. PMID 22459616.
- Dalton JT, Barnette KG, Bohl CE, et al. “The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.” J Cachexia Sarcopenia Muscle. 2011;2(3):153-161. Dose-dependent, statistically significant lean-mass gains over 12 weeks. PMID 22031847.
- U.S. Anti-Doping Agency. “Selective Androgen Receptor Modulators (SARMs).” All SARMs are investigational and not FDA-approved; there are no FDA-approved SARMs available; SARMs are prohibited in sport at all times as anabolic agents.
Compounded medications are prescription products and are not FDA-approved finished drugs; they are dispensed only after a licensed clinician’s evaluation. Talk to a qualified clinician before starting, stopping, or changing any treatment.
What actually separates a peptide from a SARM, and why does it matter for where you buy it?
Peptides are short chains of amino acids. Plenty of them, BPC-157 and TB-500 among them, can be legally compounded by a licensed pharmacy under a physician’s supervision. SARMs are synthetic small molecules built to target androgen receptors, and not one has cleared FDA approval for use in a person. That gap in the regulatory record is exactly why the two supply chains look nothing alike. Peptides have an accountable route to your door. SARMs don’t.
Does paying more get you a cleaner peptide or SARM?
Price tells you almost nothing here. Compounded peptides from a licensed pharmacy cost more than research-chemical sites, but you’re paying for actual pharmaceutical oversight, not a fancier label. Cheap SARMs sold online can be underdosed, misdosed, or something else entirely, and spending more within that same gray-market tier doesn’t fix any of it. You’re buying accountability. You are not buying milligrams.
If I want a peptide I can actually verify, where does that trail lead?
Right now, a physician-supervised compounding pharmacy is the most verifiable route available. FormBlends operates in that lane, meaning a licensed prescriber signs off and the compounding follows USP standards. Compare that to any site selling peptides or SARMs as research chemicals, where the trail stops cold at a PDF you have no way to independently confirm.
Forget the paperwork for a second, which one actually works better?
Honestly, the head-to-head data on peptides versus SARMs in healthy people barely exists, so nobody gets a clean answer here. SARMs show real body-composition effects in some trials, but those trials were studying disease states, not gym goals, and none of the compounds ever reached approval. Peptides have a narrower evidence base but a cleaner one. Trading a shaky, unverified edge for a real accountability gap is not a trade most sports medicine physicians would sign off on.
Dominic Pryce, investigative correspondent. I check the paperwork before I check the price. Last reviewed against the primary literature cited above, April 2026.
This article is educational and not a substitute for professional medical advice. Check with your doctor first.
